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http://www.ctajournal.com/content/2/1/22RESEARCH Open AccessIntact skin and not stripped skin is crucial for the
safety and efficacy of peanut epicutaneous
immunotherapy (EPIT) in mice
Lucie Mondoulet1*, Vincent Dioszeghy1, Emilie Puteaux1, Mélanie Ligouis1, Véronique Dhelft1, Franck Letourneur2,
Christophe Dupont3 and Pierre-Henri Benhamou1Abstract
Background: Epicutaneous immunotherapy (EPIT) on intact skin with an epicutaneous delivery system has already
been used in preclinical and clinical studies. In epicutaneous vaccination and immunotherapy, the stripping of skin
before application of the allergen is suggested to facilitate the passage of allergen through immune cells.
Objectives: The aim of this study was to compare the immunological response induced by EPIT performed on
intact and stripped skin in a mouse model of peanut allergy.
Methods: After oral sensitization with peanut and cholera toxin, BALB/c mice were epicutaneously treated using an
epicutaneous delivery system (ViaskinW (DBV Technologies, Paris) applied either on intact skin or on stripped skin.
Following EPIT, mice received an exclusive oral peanut regimen, aimed at triggering esophageal and jejunal lesions.
We assessed eosinophil infiltration by histology, mRNA expression in the esophagus, antibody levels and peripheral
T-cell response.
Results: EPIT on intact skin significantly reduced Th2 immunological response (IgE response and splenocyte
secretion of Th2 cytokines) as well as esophageal eosinophilia (2.7 ± 0.9, compared to Sham 19.9 ± 1.5, p < 0.01),
mRNA expression of Th2 cytokines in tissue and intestinal villus sub-atrophia (2.9 ± 0.2 vs Sham, 2.1 ± 0.2, p < 0.05).
By contrast, EPIT on stripped skin reinforced Th2 systemic immunological response as well as eosinophil infiltration
(26.8 ± 15.1), mRNA expression of Th2 cytokines and duodenal villus/crypt-ratio (2.4 ± 0.3).
Conclusions: Epicutaneous allergen-specific immunotherapy needs the integrity of superficial layers of the stratum
corneum to warranty safety of treatment and to induce a tolerogenic profile of the immune response.
Keywords: Food allergy, Immunotherapy, Epicutaneous, PeanutBackground
A new method of allergen-specific immunotherapy, via
the epicutaneous route (epicutaneous immunotherapy,
EPIT), is currently under investigation, using a unique
epicutaneous delivery system (ViaskinW, DBV Technolo-
gies, Paris, France) consisting of a central transparent
plastic membrane (11 mm in diameter) of polyethylene
electrically charged with electrostatic forces and an ad-
hesive sheath of nonwoven film. Dry powder of proteins
is maintained on the backing by electrostatic forces. An
occlusive chamber is created on the skin that rapidly* Correspondence: lucie.mondoulet@dbv-technologies.com
1DBV Technologies, Green Square, Bagneux, France
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distribution, and reproduction in any mediumgenerates moisture and releases the allergen from its
support. The allergen is then absorbed by the skin where
it interacts with epidermal immune cells [1]. EPIT con-
sists of repeated and prolonged administrations of pea-
nut protein extract on intact skin, allowing to reach the
immune system without any risk of massive transcutane-
ous passage [2]. Some encouraging results in children
severely allergic to cow’s milk [1] have been already pub-
lished as well as several studies on mice sensitized to
pollen, ovalbumin, house dust mites and peanuts [2-5].
The preclinical analysis of the different events occurring
during EPIT with ViaskinW showed that after a prolonged
application on intact skin, the allergen is taken up by den-
dritic cells in the superficial layers of the stratumtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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draining lymph nodes, with variations according to the
previous level of sensitization of the mice [2]. Contrary to
stripped skin, when the ViaskinW is applied on healthy
skin, the amount of allergen that passes freely through
the skin is very limited and the passage of the allergen is
mostly intracellular [2]. Also, recently, this action was
shown to be powerful since it prevented the gastro-
intestinal lesions induced by sustained oral exposure in
sensitized mice [5]. Interestingly, ViaskinW acts through
the application of the peanut protein extract on intact
skin contrary to all other attempts of EPIT described to
date. In epicutaneous vaccination [6,7] as well as in EPIT
[8], authors suggest stripping the skin before application
of the allergen in order to facilitate the passage through
the skin immune system. The aim of the current study
was to delineate the role of the skin preparation during
EPIT in terms of both safety and efficacy.
Methods
Reagents and mice
Peanut protein extract (PPE) used for sensitization and
immunotherapy was purchased from Greer laboratories
(Lenoir, NE, USA). The endotoxin content of 100μg of
peanut protein extract was evaluated below 50 EU (neg-
ligible values). Ara h 1 content in 500μg of PPE was esti-
mated at 2.8% (ie. 14μg) using commercial ELISA kit
(Indoor Biotechnologies, Charlottesville, VA, USA)
according to the manufacturer’s instructions. Cholera
toxin (CT) was purchased from List Biological Labora-
tories Inc. (Campbell, CA, USA).
Three-week-old female BALB/c mice (Charles River,
Lyon, France) were purchased and housed under stand-
ard animal husbandry conditions. All experiments were
performed according to the European Community rules
on animal care and with permission 92-305 from the
French Veterinary Services.
Induction of peanut allergy, EPIT treatment and induction
of esophageal and jejunal injuries
Twenty-four mice were first sensitized to peanut pro-
teins by means of 6 intra-gastric gavages (D1, D7, D13,
D19, D25, D32) as previously described [4], with 1 mg of
PPE mixed with 10μg of CT. Then, 8 sensitized mice
were treated by EPIT on intact skin (EPIT) and 8 other
sensitized mice were treated on tape-stripped skin (strip-
ping+EPIT). The last 8 sensitized mice were sham-treated
(Sham) and received an empty ViaskinW (no protein admi-
nistered on the skin). During sensitization and immuno-
therapy, all the mice were fed with standard mouse diet
free of peanut proteins; the absence of low amounts
of peanut protein was showed by a specific ELISA to
Ara h 1 validated in food matrix (Indoor Biotechnolo-
gies, Charlottesville, VA, USA). After sensitization andimmunotherapy periods, the animals were first orally chal-
lenge with high amounts of peanut proteins to measure
histamine release in blood sample and then underwent
sustained oral exposure to peanuts for 10 consecutive days
as already published [5]. Eight naive mice serving as con-
trols received the same procedures. The day after the last
challenge, mice were anesthetized and sacrificed and sam-
ple studies were performed as described above.
Epicutaneous immunotherapy (EPIT)
1/ Preparation of the skin and application of ViaskinWHair was removed from the back of mice under
anesthesia using an electric clipper and depilatory
cream without corticoid as already described [3,4].
Twenty-four hours later, after total recovery of the
skin evaluated by Trans Epidermial Water Loss
(TEWL) measurements, the ViaskinW loaded with
100μg PPE (EPIT and stripped+EPIT) and the empty
ViaskinW (Sham) were applied on the back of
anaesthetized mice. The skin was previously
tape-stripped using scotch-tape for 10 times,
changing each time the adhesive tape, for only one
treated group (stripping+EPIT).
2/ Protocol for safety concern (Figure 1a)
In order to evaluate the free passage to bloodstream
after epicutaneous administration of PPE by
ViaskinW, naive mice were received a single
application of ViaskinW loaded with 500μg of PPE
for 48h (Viaskin-500). Subcutaneous injections
(200μl containing 500μg of PPE) as positive control
of bloodstream passage were done.
3/ Protocol for efficacy concern (Figure 1b)
EPIT was performed using the epicutaneous delivery
system ViaskinW (DBV technologies, Paris France)
and the treatment protocol which has been
previously described [3,4]. Briefly, epicutaneous
treatment on intact skin or stripped skin
was done once a week for 48h during
8 consecutive weeks.
Measurement of Ara h 1 in serum samples
Blood was collected by retro-orbital bleeding in empty
tubes before the application of Viaskin-500 (t0) and 2h,
8h, 24h and 48h after the application of Viaskin-500.
Tubes were centrifuged at 10000g for 10mn and then
sera were stored at −20°C until used. Commercial ELISA
kit (Indoor Biotechnologies) was used for the quantifica-
tion of Ara h 1 in serum samples. Manufacturer’s
instructions were adapted to a measurement in serum
matrix (under the FDA 2001 guidelines). The limit of
quantification was determined at 7.8ng/ml, ie. less than
0.06% of 500μg PPE loaded into ViaskinW.
Figure 1 a-Study design for the evaluation of peanut protein passage into blood stream after epicutaneous application on intact or
stripped skin. Naive mice were divided into 3 groups (n=10 for each). One group received a ViaskinW loaded with 500μg (ViaskinW-500) applied
on intact skin (EPIT), another group received ViaskinW-500 applied on stripped skin (stripping+EPIT) and the last one received a subcutaneous
injection containing 500μg of PPE. Blood samples were taken at different time points (0, 2, 8, 24, 48h) to quantify Ara h 1 in serum. b- Study
design for the sensitization of mice to peanuts proteins and evaluation of the effect by EPIT on intact or stripped skin on the
induction of digestive lesions on esophagus and jejunum. Twenty-four mice were sensitized to peanut proteins. Then, epicutaneous
immunotherapy was conducted for 8 weeks in 8 sensitized mice on intact skin (EPIT), or in 8 sensitized mice on stripped skin (stripping+EPIT)
and 8 other sensitized mice received a Sham treatment (Sham). After an oral challenge with high amounts of peanut proteins, histamine release
was measured in blood samples. After that, a peanut regimen for 10 days was given to sensitized and naive mice. Mice were sacrificed to analyze
esophagus and jejunum samples by histology and RT-qPCR. Blood samples were taken before the beginning of immunotherapy and after the
8-week period of treatment to measure specific immunoglobulins (IgE, IgG1, IgG2a).
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IgG2a
Blood was collected by retro-orbital bleeding using tubes
containing EDTA, 10 days after the last intra-gastric ad-
ministration and at the end of sustained peanut oral ex-
posure. Plasma were stored at −20°C until used. Peanut
specific IgE, IgG1 and IgG2a levels were determined by
ELISA as described previously [3,4]. As the high level of
IgG might lead to underestimation of the sIgE level, the
ELISA method has been confirmed by a reverse enzyme
allergo-sorbent assay (EAST).Measurement of histamine release in blood samples after
oral challenge to peanuts
Histamine increase in blood reflects the percentage of
mast cells degranulation [9]. It was assayed in plasma
samples 30 minutes after peanut oral challenge as a mar-
ker of anaphylactic reaction. Mice of each group were
challenged at 30-minute intervals by 2 oral administra-
tions of 10 mg PPE diluted in 200 μl of PBS. Histamine
was assayed using a competitive enzyme immunoassay
kit (SPI-BIO, Montigny-le-Bretonneux, France) in blood
collected 30 minutes after the second oral challenge.Determination of splenocyte cytokine profiles
Following the peanut oral exposure and immediately after
sampling esophagus and jejunum segments, splenocytes
from each group were prepared as described previously
[2]. Cells were cultured in 24-well plates (2 x 106/well/ml)
in presence or absence of PPE (100μg/ml) or concanavalin
A (10μg/ml, data not shown). Supernatants were collected
after 72 hrs of culture and stored at −20°C until use. Cyto-
kine levels were determined using Bioplex cytokine assayW
(BioRad, Marnes-la-Coquette, France) according to the
manufacturer’s instructions.
Analysis of esophageal eosinophilia and jejunum villus
atrophy
Esophagus and jejunum were collected and fixed in 4%
neutral-buffered formalin and prepared for analysis as
already described [5]. Three sections of esophagus and
6 sections of jejunum were analyzed in a double-blind
manner. Eosinophils were counted by a skilled European
College of Veterinary Pathologists (ECVP) -certified
pathologist and results were expressed as number of
eosinophils per mm2. The ratio of villous height to crypt
depth was evaluated using 6 intermediate-powered fields
randomly selected around the jejuna lumen.
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by EPIT
Total RNA from esophageal sections was sampled in RNA-
laterW and extracted using RNeasy Mini Kit (Qiagen, Cour-
taboeuf, France) as already described [5]. The murine
primer sequences designed with the OLIGO6 software
package were already described. Quantitative PCR analyses
in real time were performed with the LightCyclerW480
Real-Time PCR system using SYBR-green fluorescence
(Roche Diagnostic, Mannheim, Germany) for quantification.
Results were presented as mRNA expression in the
naive, EPIT, stripping+EPIT and Sham animals. Target
gene expression was calculated relative to the expression
of βactin and SDHA in each experimental sample, using
the ΔCq method. Each set of quantitative PCR reactions
were also run with negative controls without RNA and
without RT.
Statistical analysis
The GraphPad Prism Software 5.02 (San Diego, CA, USA)
was used for statistical analysis (n=8 mice per group).
Results are expressed as mean ± standard deviation (SD).
Antibody, cytokine and mRNA expression responses were
analyzed using analysis of variance (ANOVA) and Tukey’s
test for intergroup comparison. For histological analyses,
statistical significance comparing different sets of mice
was determined by Student’s t test.
Results
Safety of epicutaneous application on intact skin as
opposed to stripped skin
In mice treated by subcutaneous injection of 500μg of
PPE, serving as positive controls of delivery into the
bloodstream, a high quantity of Ara h 1 was detected
from 2h to 48h, with a peak at 8h (147.5 ± 20.6ng/ml)
(Figure 2). When ViaskinW-500 was applied on intact
skin, no Ara h 1 was detected in the serum from 0 toFigure 2 Quantification of Ara h 1 in serum sample of mice. Quantity
administration on intact or stripped skin or subcutaneous administration of
each group.48h. When ViaskinW-500 was applied on stripped skin, a
limited quantity of Ara h 1 was detected in the serum at
2h (39.5 ± 21.2ng/ml) and 8h (10.8 ± 5.4ng/ml) after the
application. For both EPIT groups, the quantity of PPE
remaining inside the ViaskinW after 48h was measured at
a similar level (25μg for EPIT and 20μg for stripping
+EPIT, quantified by total protein assay) whereas the
quantity transferred into the skin (epidermis and dermis)
was a little higher at 2h and 8h for the intact skin group
(data not shown, 1007ng/ml and 388ng/ml for EPIT vs
677ng/ml and 146ng/ml for stripping+EPIT).Modulation of humoral/cellular responses by EPIT
depending on the integrity of epidermis
The serological responses were analyzed after both
sensitization (D42) and a 8-week EPIT (D106) (Figure 3).
No specific antibodies to PPE were detected for naive
mice. In the sham group, specific IgE increased signifi-
cantly after sensitization and were maintained during
8-week of treatment, with no modification of specific
IgG2a. When EPIT was applied on intact skin, specific
IgE decreased from D42 to D106 (from 0.14 to 0.04 μg/ml,
p<0.05) and specific IgG2a increased (from 0.56 to
3.21 μg/ml, p<0.05). To the opposite, when EPIT was
applied on stripped skin, specific IgE increased (from
0.12 to 0.38 μg/ml, p<0.01) and specific IgG2a were not
modified (0.98 vs 1.25 μg/ml, ns). The IgG1/IgG2a ratio
significantly differed between EPIT and Sham or strip-
ping+EPIT (respectively, 18 vs 228 or 227, p<0.001).
Levels of histamine released in plasma sampled 30 min
after oral challenge were higher in sham (1384 nM) than
in naive mice (317 nM, p<0.001). It was significantly
reduced by EPIT done in intact skin (369 nM, p<0.01 vs.
sham) whereas the release was still high for mice treated
by EPIT applied on stripped skin (1028 nM, p<0.01 vs
naive and EPIT).of Ara h 1 was measured in serum samples after epicutaneous
500μg of PPE. Results were expressed in ng/ml as means ± SD for
naive Sham EPIT Stripping+EPIT
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Figure 3 Systemic responses induced in mice after oral sensitization and epicutaneous immunotherapy (a) Quantity of specific IgE and
(b) specific IgG2a expressed in μg/ml. Data are expressed as means ± SD for each group, D42 after oral sensitization, D106 after
immunotherapy and sustained peanut exposure. (c) Measurement of histamine release in bloodstream after oral challenge to peanuts. Data are
expressed as means ± SD for each group. * p<0.05, ** p<0.01, *** p<0.001.
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Figure 4 Cellular responses induced in mice after oral sensitization and epicutaneous immunotherapy. Measurement of Th2 cytokine
levels (IL-4, IL-5, IL-13) and IFN-γ secretion by splenocytes collected from each group of mice (naive, Sham, EPIT, stripping-EPIT) immediately after
sacrifice. Splenocytes were prepared and stimulated with PPE for 72 hrs. Cytokines were measured by Bioplex cytokine assayW. Data are presented
as means ± SD for each group, * p<0.05, ** p<0.01.
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PPE. In sham mice, they specifically secreted Th1 and
mainly Th2 cytokines in comparison to naive mice
(Figure 4): IL-4 (46.5 vs 2.4 pg/ml, p<0.01), IL-5 (148.3 vs
11.0, p<0.01), IL-13 (154.6 vs 7.3, p<0.01) and IFN-γ
(75.9 vs 3.9, p<0.01). When mice were treated by EPIT
on intact skin, Th2 cytokines decreased: IL-4 (10.6 pg/ml
vs sham at 46.5 pg/ml, p<0.05), IL-5 (53.1 pg/ml vs sham
at 148.3 pg/ml, p<0.05), IL-13 (60.9 pg/ml vs sham at
154.6 pg/ml, p<0.05) and IFN-γ (31.4 pg/ml vs sham at
75.9 pg/ml, ns). To the opposite, when EPIT was applied
on stripped skin, the secretion of Th2 cytokines was
maintained and the Th1 pathway was down regulated:
IL-4 (33.9 pg/ml vs sham, ns), IL-5 (111.5 pg/ml vs
sham, ns), IL-13 (136.3 pg/ml vs sham, ns) and IFN-γ
(18.8 pg/ml vs sham, ns). No cytokine secretion was
detected by stimulation in medium alone.
Assessment of esophageal and jejunal lesions
Naive mice exposed to a peanut exclusive diet for
10 days did not exhibit any esophagus injuries (Figure 5a).
In the sham group, the esophagus showed a massive
infiltration with inflammatory cells, particularly eosino-
phils, in the lamina propria around the vascular plexus
or more diffusely in the most severe cases (Figure 5b).
When EPIT was applied on intact skin (Figure 5c), the
tissue sections following sustained peanut food expos-
ure exhibited lower cell infiltration in the laminapropria and epithelium than in sham, with an aspect
similar to naive mice. When EPIT was applied on
stripped skin (Figure 5d), the aspect was similar to that
of sham mice. The eosinophil infiltration in the
esophagus of sham mice (Figure 5e) was significantly
higher than in naive mice (20 eosinophils/mm2 vs
1 eosinophil/mm2, p<0.01), clearly smaller in EPIT than
in sham (3 eosinophils/mm2, p<0.01). For EPIT on
stripped skin, the high infiltration of eosinophils was
maintained (27 eosinophils/mm2), similar to sham and
higher than in EPIT on intact skin (p<0.05).
At the molecular level, esinophil infiltration was ac-
companied by an increased esophageal expression of
eotaxin, IL-5, IL-13, GATA-3 and Tbet mRNA for Sham
group (Figure 6). EPIT on intact skin reduced the expres-
sion of Th2 cytokines as indicated by significantly lower
mRNA levels vs sham for eotaxin, IL-5, IL-13 and
GATA-3 (p<0.05) and had no effect on Tbet. The expres-
sion of FoxP3 was significantly higher after EPIT com-
pared with the sham and naive groups (p<0.05). When
EPIT was applied on stripped skin, Th2 cytokine
(eotaxin, IL-5, IL-13, GATA-3) mRNA levels were similar
to those obtained for sham group and no induction of
FoxP3 mRNA was observed in comparison to EPIT on
intact skin (respectively, 0.5 vs 2.6, p<0.001).
In the jejunum, sustained oral exposure to peanuts was
associated with obvious jejunal lesions (Figure 7). Com-
pared with naive mice, the recruitment of inflammatory
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Figure 5 Effect of EPIT on intact or stripped skin on the induction of injuries in esophagus. Microscopic analysis of eosinophils in the
esophagus at 100x high-powered fields (a-d). Most eosinophils are located in the lamina propria, submucosa and epithelial layer of the Sham and
stripping-EPIT groups and to a lesser extend of the EPIT group. A difference in the thickness of epithelium is observed between naïve/EPIT and
Sham/stripping+EPIT. (e) For eosinophils, the results are expressed as number of eosinophils per mm2 and data are presented as means ± SD for
each group, * p<0.05, ** p<0.01.
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phils in Sham group (Figures 7a and 7b), this infiltration
was quantified to 519 eosinophils/mm2 vs 214 eosino-
phils/mm2 into naive mice (p<0.001). After EPIT on
intact skin, the tissue sections of the jejunum obtained
following the peanut exclusive diet showed a sub-mucosal
eosinophilic infiltration that was reduced compared with
sham (440 eosinophils/mm2 vs 519 eosinophils/mm2,
p<0.05). When EPIT was done on stripped skin, theeosinophilic infiltration of the jejunum was maintained at
a similar level than Sham group (638 eosinophils/mm2).
The sustained oral exposure to peanuts induced a de-
gree of villus sub-atrophy (Figure 8) with, in the sham
group, an overall decrease in villous height and increase
in crypt depth, which significantly decreased the villus/
crypt ratio compared with naive mice (2.2 vs 3.4,
p<0.001). EPIT on intact skin prevented the modification
of the villus height and the crypt depth observed with
a           eotaxin b           IL-5 c           IL-13
d           T-bet e           GATA-3 f           FoxP3
Figure 6 Effect of EPIT on intact or stripped skin on the mRNA expression of cytokines and transcription factors in esophagus mucosa.
Cytokine mRNA from esophagus segments collected 24 hrs after stopping peanut diet was assayed by RT-qPCR. Results are presented as mRNA
expression of naïve, Sham, or EPIT animals. The relative levels of gene expression were calculated by reference to mRNA levels of SDHA and
β-actin in each sample. (a) eotaxin, (b) IL-5, (c) IL-13, (d) T-bet, (e) GATA-3, (f) FoxP3. * p<0.05, ** p<0.01 , *** p<0.001.
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vs Sham), and was similar to that in naive mice. When
EPIT was applied on stripped skin, the aspect of villi
and the villus/crypt ratio was similar to that of sham
group, a (2.4, p<0.05 vs naive).
Discussion
This study suggests that EPIT using ViaskinW is efficient
only when applied on intact skin.
In the present study, the immune response generated
by ViaskinW appears to be strongly influenced by the
condition of the skin. When ViaskinW has been applied
on intact skin, the profile of the immune response gen-
erated by the treatment is predominantly Th1/Treg
whereas in case of ViaskinW applied on stripped skin, it
is clearly Th2 oriented. The current work strongly sug-
gests that during EPIT, skin preparation, ie. removing
the stratum corneum layer and damaging epidermis,
dramatically alters the outcome of treatment and immune
reaction.
Skin stripping has never been investigated during the
course of EPIT, but has long been considered an enhan-
cing factor of sensitization. Tape-stripping in mice was
shown to act as a natural adjuvant. Indeed, according to
Strid et al. [10-12] and Spergel et al. [13], the application
of antigen wihout adjuvant on previously stripped skin
in naive mice switches the antigen-specific T helper cell
responses from Th1-type to Th2-type: epicutaneous
immunization on stripped skin converts an establishedTh1 response (induced by previous subcutaneous injec-
tion with adjuvant) into a Th2 response, with a specific
reduction of IFN-γ and IgG2a and the enhancement of
IL-4 and IgE. In model of food allergy in which mice
were sensitized by epicutaneous application of ovalbu-
min on skin abraded by tape-stripping [14], mice devel-
oped diarrhea and accumulated mast cells in the small
intestine, while vast amounts of MMCP-1were released
from these cells into the circulation.
In vaccination models, a strong immune reaction was
induced by application of antigen on the skin together
with an adjuvant [6,7,15]. In these models, antigen and
adjuvant were applied on the skin previously prepared
by gentle removal of the superficial layer of the stratum
corneum in order to enhance the transcutaneous pas-
sage of both the antigen and adjuvant. The immune
responses were clearly Th2 oriented and results consist-
ent with those reported here.
The importance of the state of skin in the profile of
immune response on contact with antigen has also been
illustrated in humans by Lack et al. [16], showing that
the exposure of skin to peanut proteins may facilitate
the sensitization process in very young children, when
the normal architecture of the skin is altered by local or
generalized eczema [16-18].
In our experiments, EPIT induced on intact skin a major
decrease in specific IgE together with a huge increase in
specific IgG2a whereas on stripped skin it reinforced
specific IgE and did not modify specific IgG2a. The
naive Sham EPIT Stripping+EPIT
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Figure 7 Effect of EPIT on intact or stripped skin on the induction of jejunal lesions jejunum segments collected and analyzed by
microscopy after HES coloration (x40). (a-d) Inflammatory infiltration, particularly of eosinophils is shown. (e) quantification of the eosinophilic
infiltration into jejunal mucosa. The results are expressed as number of eosinophils per mm2 and data are presented as means ± SD for each
group, * p<0.05, *** p<0.001.
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http://www.ctajournal.com/content/2/1/22opposite modulation of humoral response was illustrated
by the IgG1/IgG2a ratio that slightly decreased with
EPIT on intact skin and significantly increased with
EPIT on stripped skin. Moreover, at a systemic level,
after oral challenge, histamine release was lower when
mice were treated by EPIT on intact skin than on
stripped skin. At the cellular level, splenocytes of EPITgroup secreted lower levels of Th2 cytokines than sensi-
tized and untreated mice.
However, in clinical situations, stripping of the skin
appears not to be playing the same “clear-cut” role. In-
deed, mouse skin is more sensitive to tape-stripping than
human skin. In a recent paper, Senti et al. [8,19] treated
patients allergic to pollen by repeated applications of
naive Sham EPIT Stripping+EPIT
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c           EPIT d           stripping + EPIT
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Figure 8 Effect of EPIT on intact or stripped skin on the induction of villus sub-atrophia. Measurement of the ratio of the villous height by
crypt depth for each group under 10x high powered fields. Results are expressed as means ± SD, * p<0.05, *** p<0.001.
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http://www.ctajournal.com/content/2/1/22pollen extract on a previously stripped skin with encour-
aging results. Despite no improvement in the provoca-
tion test, the primary outcome, in the active group
versus the control group always showed a significant
improvement of the seasonal symptoms (hay fever).
The patch was applied for 48 hours on the skin prepared
by 6 times tape-stripping.
In this study, we showed that EPIT on stripped skin
leads to a free passage of allergens (ie. Ara h 1) into the
bloodstream whereas no detectable level is measured
when EPIT was applied on intact skin. The kinetics of
allergen delivery is different: application on stripped skin
induces a passive passage of allergens through the skininto the lymphatics, with high counts in the dermis and
numerous allergen-positive cells in draining LNs as
early as 2h after application [20] (paper in preparation).
Dendritic cells targeted by the two modes of application
of EPIT (intact vs stripped skin) exhibit different pheno-
types in term of activation and maturation [20] (paper in
preparation).Taken together - allergen specific capture by
DCs through LNs and no detectable level of allergen in
bloodstream - these results underline the safety of appli-
cation only on intact skin. Importantly, these data are
consistent with clinical observations. In the human trial,
some local adverse events (33% of patients) and systemic
allergic reactions required intervention (8% of patients)
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http://www.ctajournal.com/content/2/1/22during the dose-effect study [19]. In children severely al-
lergic to cow’s milk treated by EPIT on intact skin, no se-
vere adverse event was reported [21].
The application on stripped skin clearly allows the
passive and massive passage of allergen through the skin
into the lymphatics [2] completely modifying the biodis-
tribution of allergen and the targeted cells, i.e. less acti-
vated Langerhans cells. Tape-stripping also triggers
mechanical injuries which activate keratinocytes and
upregulate thymic stromal lymphopoietin (TSLP) expres-
sion by keratinocytes and mRNA expression of inflamma-
tory cytokines, all of them involved in the polarization of
skin DCs to elicit a Th2 response seeing that a link
between TSLP expression and the pathogenesis of AD
has been shown in several mouse models [22-24]. By
contrast, in a recent paper, Li et al. (2012) describe an
epicutaneous treatment on intact skin to prevent oral
food sensitization in a mouse model [25]. More specif-
ically, the authors showed that high-dose PPE cutane-
ous application on intact skin is capable of promoting
skin local regulatory T-cell responses. At a systemic
level, their results showed that the defined exposure of
food allergens to intact skin suppresses the subsequent
food allergy oral sensitization with suppression of multiple
Ig isotypes (IgE, IgG1, IgG2a). Altogether, this greatly sug-
gests that for treatment of Th2 disease, such as immuno-
therapy of food allergy, avoiding tape-stripping could be of
importance, leading to efficacy of EPIT and to maintain
the safety of the treatment. The mechanisms involved with
the epicutaneous allergen application for the treatment of
food allergy are being explored (data submitted for publi-
cation) and is likely due to a specific targeting to Langher-
ans cells responsible to antigen presentation to T cells in
lymph nodes and Treg expansion [26].
The model of peanut-sensitized mice exposed to sus-
tained peanut oral regimen in order to induce esopha-
geal and jejunum injuries was recently published [5].
The digestive tract is one of the main organs targeted
during food allergies. Based on our previous model
developed for the evaluation of new therapeutics in the
field of food allergies [5], we compared the eosinophilic
infiltration in mice treated by EPIT on intact or stripped
skin. As already published, the decrease of the digestive
eosinophil infiltration induced by the ingestion of peanut
in sensitized mice treated by EPIT on intact skin was
accompanied by a significant decrease of mRNA expres-
sion of Th2 cytokines, eotaxin and GATA-3 as well as an
increase of FoxP3, underlining the involvement of Tregs
in down-regulation of the Th2 pathway. EPIT on stripped
skin maintain the high infiltration of eosinophil in je-
junum mucosa as well as the villus sub-atrophia, did
not induce any increase in mRNA expression of FoxP3
and maintain the high mRNA expression of Th2 cyto-
kines and GATA-3.Conclusion
In conclusion, epicutaneous immunotherapy through
repeated applications of allergen should be performed
on normal, non-inflamed skin, ie. intact skin, in order to
insure the safety of the treatment by avoiding a massive
free passage of the allergen into the blood stream but
also to induce a tolerogenic immune profile.
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